These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17687597)

  • 1. Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma.
    Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
    World J Surg; 2007 Oct; 31(10):2016-22. PubMed ID: 17687597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
    Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
    World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery for periductal infiltrating type intrahepatic cholangiocarcinoma without hilar invasion provides a better outcome than for mass-forming type intrahepatic cholangiocarcinoma without hilar invasion.
    Imai K; Yamamoto M; Ariizumi S
    Hepatogastroenterology; 2010; 57(104):1333-6. PubMed ID: 21443080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement.
    Shimada K; Sano T; Nara S; Esaki M; Sakamoto Y; Kosuge T; Ojima H
    Surgery; 2009 Apr; 145(4):411-6. PubMed ID: 19303990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma?
    Yamamoto M; Takasaki K; Yoshikawa T; Ueno K; Nakano M
    J Surg Oncol; 1998 Nov; 69(3):162-7. PubMed ID: 9846503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periductal infiltrating type of intrahepatic cholangiocarcinoma: a rare macroscopic type without any apparent mass.
    Uno M; Shimada K; Yamamoto Y; Nara S; Esaki M; Sakamoto Y; Kosuge T; Ojima H
    Surg Today; 2012 Dec; 42(12):1189-94. PubMed ID: 22350300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes.
    Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Kinoshita H
    Hepatogastroenterology; 2002; 49(44):326-9. PubMed ID: 11995443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological characteristics of intrahepatic cholangiocellular carcinoma presenting intrahepatic bile duct growth.
    Yamamoto Y; Shimada K; Sakamoto Y; Esaki M; Nara S; Ban D; Kosuge T; Ojima H
    J Surg Oncol; 2009 Mar; 99(3):161-5. PubMed ID: 19101954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.
    Miwa S; Miyagawa S; Kobayashi A; Akahane Y; Nakata T; Mihara M; Kusama K; Soeda J; Ogawa S
    J Gastroenterol; 2006 Sep; 41(9):893-900. PubMed ID: 17048054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology.
    Itamoto T; Asahara T; Katayama K; Nakahara H; Fukuda T; Yano M; Hino H; Nakahara M; Dohi K; Shimamoto F
    Hepatogastroenterology; 2001; 48(40):1129-33. PubMed ID: 11490816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.
    Ebata T; Nagino M; Kamiya J; Uesaka K; Nagasaka T; Nimura Y
    Ann Surg; 2003 Nov; 238(5):720-7. PubMed ID: 14578735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
    Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
    J Surg Oncol; 2007 Aug; 96(2):160-5. PubMed ID: 17443744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival of patients with cholangiolocellular carcinoma after curative hepatectomy.
    Ariizumi S; Kotera Y; Katagiri S; Nakano M; Nakanuma Y; Saito A; Yamamoto M
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3(Suppl 3):S451-8. PubMed ID: 24633664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
    de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
    Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma.
    Bagante F; Spolverato G; Weiss M; Alexandrescu S; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
    Ann Surg Oncol; 2017 Sep; 24(9):2491-2501. PubMed ID: 28466403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index.
    Shirabe K; Mano Y; Taketomi A; Soejima Y; Uchiyama H; Aishima S; Kayashima H; Ninomiya M; Maehara Y
    Ann Surg Oncol; 2010 Jul; 17(7):1816-22. PubMed ID: 20135355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
    Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival.
    Ohtsuka M; Ito H; Kimura F; Shimizu H; Togawa A; Yoshidome H; Miyazaki M
    Br J Surg; 2002 Dec; 89(12):1525-31. PubMed ID: 12445060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment.
    Sasaki A; Aramaki M; Kawano K; Morii Y; Nakashima K; Yoshida T; Kitano S
    Br J Surg; 1998 Sep; 85(9):1206-9. PubMed ID: 9752860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan.
    Isaji S; Kawarada Y; Taoka H; Tabata M; Suzuki H; Yokoi H
    J Hepatobiliary Pancreat Surg; 1999; 6(2):108-16. PubMed ID: 10398896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.